{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:24:11Z","timestamp":1787747051902,"version":"build-2784847793"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,26]]},"DOI":"10.7759\/cureus.115220","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:08:15Z","timestamp":1787746095000},"source":"Crossref","is-referenced-by-count":0,"title":["Solitary Testicular Metastasis as the Only Site of Recurrence in Prostate Adenocarcinoma"],"prefix":"10.7759","author":[{"given":"Mohamed Amine","family":"Harchaoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brahim","family":"Masaoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha","family":"Azzakhmam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Ameur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein JI","year":"2016","unstructured":"Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA. The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol. 2016, 40:244-252. 10.1097\/PAS.0000000000000530","journal-title":"Am J Surg Pathol"},{"key":"ref2","article-title":"Metastasis to testis and testicular adnexa of prostate adenocarcinoma in two high complexity centers in the cities of Bogota and Medellin: a case series","volume":"12","author":"Londo\u00f1o DR","year":"2024","unstructured":"Londo\u00f1o DR, Varela R, Reyes EC, Ni\u00f1o Vargas DC, Giraldo Villegas C, Aristizabal Mazo D. Metastasis to testis and testicular adnexa of prostate adenocarcinoma in two high complexity centers in the cities of Bogota and Medellin: a case series. MOJ Surg. 2024, 12:23-25.","journal-title":"MOJ Surg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/hp.2000.6698","article-title":"Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients","volume":"31","author":"Bubendorf L","year":"2000","unstructured":"Bubendorf L, Sch\u00f6pfer A, Wagner U, et al.. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol. 2000, 31:578-583. 10.1053\/hp.2000.6698","journal-title":"Hum Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.78571","article-title":"Isolated testicular metastasis from prostate cancer: a rare presentation 15 years posttreatment","volume":"17","author":"Waraich TA","year":"2025","unstructured":"Waraich TA, Khalid SY, Aslam A, Lizarralde C, Jaffry S. Isolated testicular metastasis from prostate cancer: a rare presentation 15 years posttreatment. Cureus. 2025, 17:e78571. 10.7759\/cureus.78571","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eucr.2025.103080","article-title":"Isolated testicular metastasis from prostate cancer following three years of hormone therapy and radiotherapy","volume":"61","author":"Tabibi A","year":"2025","unstructured":"Tabibi A, Zabihi MS, Najarian M, Dadpour M. Isolated testicular metastasis from prostate cancer following three years of hormone therapy and radiotherapy. Urol Case Rep. 2025, 61:103080. 10.1016\/j.eucr.2025.103080","journal-title":"Urol Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.269361","article-title":"Prostate cancer recurrence due to isolated testicular metastases detected by PSMA PET\/CT","volume":"66","author":"de Oliveira Taveira M","year":"2025","unstructured":"de Oliveira Taveira M, Razmaria AA, Schoder H, Yeh R. Prostate cancer recurrence due to isolated testicular metastases detected by PSMA PET\/CT. J Nucl Med. 2025, 66:892-895. 10.2967\/jnumed.124.269361","journal-title":"J Nucl Med"},{"key":"ref7","unstructured":"BioGenex. IHC panel markers - prostate & testicular cancer. (2026). Accessed. April 6, 2026: https:\/\/biogenex.com\/wp-content\/uploads\/2021\/04\/Panel-09-Prostate-and-Testicular-Cancer.pdf."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18061151","article-title":"Sensitivity of HOXB13 as a diagnostic immunohistochemical marker of prostatic origin in prostate cancer metastases: comparison to PSA, prostein, androgen receptor, ERG, NKX3.1, PSAP, and PSMA","volume":"18","author":"Kristiansen I","year":"2017","unstructured":"Kristiansen I, Stephan C, Jung K, Dietel M, Rieger A, Tolkach Y, Kristiansen G. Sensitivity of HOXB13 as a diagnostic immunohistochemical marker of prostatic origin in prostate cancer metastases: comparison to PSA, prostein, androgen receptor, ERG, NKX3.1, PSAP, and PSMA. Int J Mol Sci. 2017, 18:1151. 10.3390\/ijms18061151","journal-title":"Int J Mol Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/1746-1596-2-41","article-title":"Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinoma","volume":"2","author":"Yin M","year":"2007","unstructured":"Yin M, Dhir R, Parwani AV. Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinoma. Diagn Pathol. 2007, 2:41. 10.1186\/1746-1596-2-41","journal-title":"Diagn Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181e6cbf3","article-title":"NKX3.1 as a marker of prostatic origin in metastatic tumors","volume":"34","author":"Gurel B","year":"2010","unstructured":"Gurel B, Ali TZ, Montgomery EA, et al.. NKX3.1 as a marker of prostatic origin in metastatic tumors. Am J Surg Pathol. 2010, 34:1097-1105. 10.1097\/PAS.0b013e3181e6cbf3","journal-title":"Am J Surg Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.5_suppl.140","article-title":"Metastasis-directed therapy (MDT) plus androgen deprivation therapy (ADT) for oligometastatic prostate cancer (omPC): primary results of the EXTEND continuous ADT (cADT) basket plus combined analysis with the updated intermittent ADT (iADT) basket and immune correlatives","volume":"43","author":"Sherry AD","year":"2025","unstructured":"Sherry AD, Haymaker CL, Fellman BM, et al.. Metastasis-directed therapy (MDT) plus androgen deprivation therapy (ADT) for oligometastatic prostate cancer (omPC): primary results of the EXTEND continuous ADT (cADT) basket plus combined analysis with the updated intermittent ADT (iADT) basket and immune correlatives. J Clin Oncol. 2025, 43:140. 10.1200\/JCO.2025.43.5_suppl.140","journal-title":"J Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(25)00658-8","article-title":"Metastasis-directed therapy and standard of care versus standard of care for oligometastatic prostate cancer (WOLVERINE): a systematic review and individual patient data meta-analysis from the X-MET collaboration","volume":"27","author":"Tang C","year":"2026","unstructured":"Tang C, Sherry AD, Hwang H, et al.. Metastasis-directed therapy and standard of care versus standard of care for oligometastatic prostate cancer (WOLVERINE): a systematic review and individual patient data meta-analysis from the X-MET collaboration. Lancet Oncol. 2026, 27:181-190. 10.1016\/S1470-2045(25)00658-8","journal-title":"Lancet Oncol"},{"key":"ref13","unstructured":"Malecare. Guide to oligometastatic prostate cancer. (2026). Accessed. April 6, 2026: https:\/\/malecare.org\/advanced-prostate-cancer\/oligometastatic-prostate-cancer\/."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/494707-solitary-testicular-metastasis-as-the-only-site-of-recurrence-in-prostate-adenocarcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:08:16Z","timestamp":1787746096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/494707-solitary-testicular-metastasis-as-the-only-site-of-recurrence-in-prostate-adenocarcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.115220","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,26]]}}}